Concepedia

Paul C. Trippier

PC

31

Publications

1.1K

Citations

17

H-Index

2003

Active since

Affiliations

Texas Tech University(Current)

Texas Tech University Health Sciences Center

University of Nebraska Medical Center

Nebraska Medical Center

Translational Therapeutics (United States)

Paul C. Trippier is an author at Texas Tech University specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2003–2023

31

Publications

31

Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications

Paul C. Trippier, Christopher McGuigan · MedChemComm · 2010 · 330 citations

, , +18

Potent and Highly Selective Aldo–Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia

Kshitij Verma, Tianzhu Zang, T.M. Penning et al. · Journal of Medicinal Chemistry · 2019 · 59 citations · Full text

Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5

Hezhen Wang, Bader Huwaimel, Kshitij Verma et al. · ChemMedChem · 2017 · 56 citations · Full text

AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells

Kshitij Verma, Nehal Gupta, Tianzhu Zang et al. · Molecular Cancer Therapeutics · 2018 · 55 citations

The Oxazolomycins: A Structurally Novel Class of Bioactive Compounds

Mark G. Moloney, Paul C. Trippier, Muhammad Yaqoob et al. · Current Drug Discovery Technologies · 2004 · 52 citations

Rows per page

1–5 of 31